Current data suggest that MLA would most likely be classified in the NSMP category as it is typically p53 wild-type, MMR proficient, and not part of the POLEmut endometrial cancer group due to its high recurrence rate and frequent distant metastasis. This evidence concerns the gene MRC1 and endometrial cancer.